Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Seng, Lee Lim"'
Autor:
Marion G. Peters, Joe Sasadeusz, Seng Lee Lim, Andrew Grigg, Peter Hughes, Monica A. Slavin, Geoff McColl, Joseph Doyle, James A Rickard, Kumar Visvanathan, Sue-Anne McLachlan, Peter De Cruz, Michaela Lucas, Vijaya Sundararajan, Nicholas A. Shackel, Robert G. Gish, Alexander J. Thompson
Publikováno v:
Clinics in Liver Disease. 23:493-509
Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occurrence in patients with hematological malignancies or some solid tumors, who are treated with immunosuppressive therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef90b8362e9563a720332e47c33ff40
https://doi.org/10.1016/j.cld.2019.04.010
https://doi.org/10.1016/j.cld.2019.04.010
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng, Lee Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases treated with aggressive immunotherapy, reactivation of hepatitis B occurs in a substantial number of patients. The risk of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0acaf91d1ac3937898aba7a453c310b8
https://pubmed.ncbi.nlm.nih.gov/31266625
https://pubmed.ncbi.nlm.nih.gov/31266625
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng Lee, Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Patients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppression, in patients who have ever been exposed to hepatitis B it is possible for reactivation to occur. This reactivation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a85f9cfe273323ddd35169f28583574c
https://pubmed.ncbi.nlm.nih.gov/31266624
https://pubmed.ncbi.nlm.nih.gov/31266624
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng, Lee Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occurrence in patients with hematological malignancies or some solid tumors, who are treated with immunosuppressive therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e08cb6647f4cc17657ba46f427eead19
https://pubmed.ncbi.nlm.nih.gov/31266622
https://pubmed.ncbi.nlm.nih.gov/31266622
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng, Lee Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients require long-term immunosuppression. In patients who have ever been exposed to hepatitis B, it is possible for reactivati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a765ad367d8eaa11230d6ea9c7571748
https://pubmed.ncbi.nlm.nih.gov/31266623
https://pubmed.ncbi.nlm.nih.gov/31266623